Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Pazopanib, a promising option for the treatment of aggressive fibromatosis.
Relationship of occupational therapy inpatient rehabilitation interventions and patient characteristics to outcomes following spinal cord injury: the SCIRehab project.
Retinal Dysplasia
The hypertension peril and drug development.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pazopanib, a promising option for the treatment of aggressive fibromatosis.
Pazopanib, a promising option for the treatment of aggressive fibromatosis. Anticancer Drugs. 2017 04; 28(4):421-426.
View in:
PubMed
subject areas
Adult
Female
Fibromatosis, Aggressive
Humans
Indazoles
Male
Middle Aged
Protein Kinase Inhibitors
Pyrimidines
Retrospective Studies
Sulfonamides
authors with profiles
Robin Jones